glp-1 uk surge: How clinics can meet demand and avoid delays | Bolt Pharmacy posted on the topic GLP-1 Lowest Cost Options: NHS

For example, Ozempic is approved to decrease the risk of kidney disease and death from cardiovascular disease in people with Type 2 diabetes

Earlier this month, the FDA posted four warning letters to companies that have introduced unapproved GLP-1s, such as semaglutide, tirzepatide, and retatrutide, into interstate commerce

Rev Diabetic Stud RDS 11(34):202230

Because the available evidence is heterogeneous in design, population, exposure, and endpoint definition, this review was not designed as a systematic review or meta-analysis

The apitegromab group lost about the same total weight as the placebo group, but the composition of that weight loss was meaningfully different: 85% of the lost weight was fat in the apitegromab group, compared to 70% fat in the placebo group